Navigation Links
eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
Date:6/19/2008

PHILADELPHIA, June 19 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (Nasdaq: ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today the availability of the EXPeRT(R) ePRO Suicidality Monitoring System(TM) (SMS). Suicidality screening is required in a growing number of drug development programs as a part of effective drug profiling and subject safety monitoring in clinical trials. The SMS was developed to address regulatory concerns and reduce the cost and time associated with clinician-administered suicidality assessments. It will also improve the quality of suicidality assessments compared to those performed by clinicians alone. SMS was developed in conjunction with Drs. John Greist, Alan Gelenberg, James Mundt, David Katzelnick and Jeff Jefferson. It is the most recent addition to a growing line of telephone-based assessments within the EXPeRT(R) ePRO services offered by eRT.

SMS is a simple patient monitoring and alert tool. It enhances subject comfort while generating critical information for site research staff and investigators in evaluating suicidality risk factors. It is easily added to any clinical trial. If a potential suicidality signal is detected for a subject, the SMS promptly alerts the investigator site to permit more in-depth clinical follow-up and evaluation.

Dr. John Greist, an eRT consultant with decades of experience and research on computer interviewing, described some of the benefits of SMS: "SMS provides a user-friendly telephone interface as a computer terminal to collect sensitive suicidality data directly from trial subjects. Advantages of Interactive Voi
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
2. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
3. Oridion Announces Major Medical Research and Congress Presentations
4. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
5. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
6. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
7. Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device
8. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
9. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
10. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
11. XTENT Announces European Regulatory Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , WALTHAM, Mass., Dec. 3 Dec...ch and advisory firms focusing on pharmaceutical a...abetes drug market in Brazil will grow from $417 m...ted 15 percent annual growth rate is attributed to...increased use of new generation antidiabetics such...
(Date:12/3/2009)...SAN DIEGO, Dec. 3 Amira Pharmace...a from a Phase 1 clinical study of AM461, the Comp...(also known as CRTH2) receptor. ,, The interi...rmacodynamic (PD) effect can be achieved with AM46...strates a good safety profile. AM461 is a back-up...
(Date:12/3/2009)..., NANJING, China, Dec. 3 /PRNewswire-Asia/ ..."Company") (NYSE: SCR ), a leading pharmaceutica...turing, and marketing of branded,generic and propr...at China,s,State Food and Drug Administration ("SF...nto quality issues regarding human use rabies vacc...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Scientists demonstrate importance of niche differences in biodiversity 9554 1Scientists demonstrate importance of niche differences in biodiversity 9554 2Erik Estrada Accepts Honorary Appointment from Project Lifesaver International 54365 1Erik Estrada Accepts Honorary Appointment from Project Lifesaver International 54365 2Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 1Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 2Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 3
...n who adhere to a traditional Mediterranean diet -...le grains and fish -- are at a lower risk for stro...y published this week in Circulation: Journal... . , , The research, led by Simmons College Nut...se diets most closely resembled the Mediterranean ...
...ruary 17 Sanofi Pasteur, the,vaccines division of...NY),announced today that it is sponsoring a phase ... difficile, which is among the most common causes ... America. , The trial currently conducted in t...efficacy of sanofi pasteur,s C. difficile candidat...
Other Medicine Technology:Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet 2Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet 3Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 2Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 3Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 4Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 5
(Date:12/3/2009)...Newswire/ -- The American Medical Association (AMA...Court for the Southern District of New York has gr...osed $350 million settlement that would resolve a ..., The action brought by the AMA, Medical Societ...cal Association, along with several other plaintif...
(Date:12/3/2009)...nimally invasive procedures, study finds , ...lly fatal blood clots after surgery are a much gre...ish study finds. , "What is most striking is th...much longer than people have thought," said Dr. Ja...ity of Oxford and a leader of the team reporting t...
(Date:12/3/2009)...ing of diabetes, cardiovascular disease, researche...ews) -- Pregnant women who develop gestational glu...isk for metabolic syndrome three months after they...ucose intolerance is less severe than gestational ... factors (including high blood pressure, obesity a...
(Date:12/3/2009)...hether they cause brain cancer, , , THU...nes cause brain cancer has been a subject of ongoi...nce suggesting that they don,t. , A 30-year exa...inavia found no substantial change in prevalence e...ing to the report in the Dec. 3 online edition of ...
(Date:12/3/2009)...The day has come. Eight months in the planning, de...re RN organizations will gather in Phoenix Monday,... 150,000-member National Nurses United, the larges...story. ,, AFL-CIO President Richard Trumka will... will chart a course for the building of a more po...
Breaking Medicine News(10 mins):Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Blood Clot Threat After Surgery Worse Than Thought 2Health News:Blood Clot Threat After Surgery Worse Than Thought 3Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:RN SuperUnion Founding Convention Opens Monday 2
..., 2009 -- The device looks deceptively simple a p...ket with a spigot but Vinka Craver believes it ca...nt professor of civil and environmental engineerin... becomes safe to drink., "More than one billion ...
...National Safety Council will host a National Poiso... National Poison Prevention Week Council, Tuesday,... Club in Washington, D.C. The event will feature a...duation. Other speakers will include: , , , ,...
...etary of Labor Hilda L. Solis today announced the ...king (ANPRM) for occupational exposure to food fla...ill facilitate the Labor Department,s Occupational...y fatal lung disease associated with such an expos...
... Medical, Inc., manufacturer of the CryoSpray Abla...f its newly redesigned Web site ( www.CSAmedical.c.../prnh/20080721/NEM114LOGO ) , , The Web site fea...e and destroy unwanted tissue in the body. The upd...
...ntertechPira,s 2009 Applications of High-Power Sem...er 15 - 17, 2009 in San Diego, CA , ... Applications of High-Power Semiconductor Lasers (...PSL 2009 will be divided into sectors reflecting i...
..., 2009 A new study published in Epilepsia finds... as high in people with epilepsy compared to the g...al minorities have seven times the odds of depress...ng mental healthcare services. , Data from the 20...
Other Medicine News:Health News:Engineer helps poor in developing nations purify drinking water 2Health News:NSC Hosts National Poison Prevention Week News Conference, Tuesday, March 17 2Health News:U.S. Secretary of Labor Hilda L. Solis takes action to prevent workers' exposure to food flavorings chemical 2Health News:CSA Medical, Inc. Announces Launch of New Web Site for Spray Cryotherapy 2Health News:Call for Presentations: Applications of High-Power Semiconductor Lasers Conference & Exhibit 2Health News:Depression twice as likely in seizure sufferers 2
5.5mm Trephine Handle
10.0mm Calibrated Trephine Handle
8.25mm Calibrated Trephine Handle
6.5mm Calibrated Trephine Handle
Medicine Products: